1. m6A-dependent mature miR-151-5p accelerates the malignant process of HNSCC by targeting LYPD3
   Fei Huang et al, 2024, Molecular Biomedicine CrossRef
2. LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia
   Tingting Hu et al, 2022, Frontiers in Genetics CrossRef